Assessment of lipid-lowering treatment in France FRESH-PEF6396-en Jean FERRIÈRES Assessment of lipid-lowering treatment in France CEPHEUS FRESH-PEF6396-en 6396 FRESH-PEF6396 Jean FERRIERES CENTRE HOSPITALIER UNIVERSITAIRE DE TOULOUSE (CHUT) ASTRAZENECA (FRANCE) Epidemiology France Portal (PEF) ASTRAZENECA (FRANCE) null Jean;FERRIERES Guidelines LDL cholesterol Lipid-lowering drugs Statins France Cardiology and vascular medicine Hematology Determine the proportion of patients on lipid-lowering drugs who reach the LDL-C goals recommended in guidelines. null Belgium France Greece Ireland Finland Turkey Luxembourg Individuals Patients population Male Female Young Adult (19 to 24 years) Adult (25 to 44 years) Middle Aged (45 to 64 years) Aged (65 to 79 years) man or woman - adult - treated with lipid-lowering drugs for at least three months, with no dose adjustment for a minimum of six weeks Clinical data Participant-reported health data Biological data Health event/morbidity Health care consumption and services One-time cross-sectional study Other [1000-10000[ individuals Converting or copying information into a structured record Interview with the participant (including clinical) Observational Study Observational Study 1966 french subjects Completed study Restricted access Contact the principal investigator Access on specific project only